CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CARTHAGO aims to advance non-viral gene therapy for treating intervertebral disc degeneration and osteoarthritis. The project focuses on innovative delivery methods and training young researchers in various disciplines to enhance treatment accessibility and effectiveness.
Chronic low back pain due to intervertebral disc (IVD) degeneration and osteoarthritis (OA) worldwide impact human health and well-being due to pain and impaired mobility.
Non-viral gene therapy has great promise as safe and precision treatment to restore IVD and joint tissue health.
However, the lack of accessibility of the affected cartilaginous tissues to drugs has inhibited progress in this field.
We will finally fulfil the promise of non-viral gene therapy in these diseases.
We will do this…
UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, Uppsala
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Romania, Cluj-Napoca
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Denmark, Aarhus C
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Finland, Espoo
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
